Drug Approval | September 28, 2024
FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Developed in consultation with clinicians and patients for an enhanced user experience
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The company will also share results in two additional posters for deuruxolitinib
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Subscribe To Our Newsletter & Stay Updated
